Modalert vs Waklert: Ingredients, Duration and Brand Differences

Updated November 11, 2026 by | Reviewed by William Gallagher, MNeuroSci
(Estimated reading time: 4 minutes)

Modalert contains modafinil, while Waklert contains armodafinil. Both appear in Sun Pharma's Indian product catalog. Their main difference is molecular: modafinil contains two mirror-image forms, whereas armodafinil contains the longer-lasting R form alone.[1][2]

That distinction changes the concentration profile over the day. It also means that a 200 mg Modalert tablet and a 150 mg Waklert tablet are different drug formulations, not simply different pack sizes of the same product.

Modalert vs Waklert at a Glance

Sun Pharma lists the following strengths. These product details provide a starting point before comparing the pharmacology and trial outcomes.

FeatureModalertWaklert
Active ingredientModafinilArmodafinil
Molecular formsR and S mixtureR form
Listed strengths100 mg and 200 mg50 mg and 150 mg
CompanySun PharmaSun Pharma

Both active ingredients are wakefulness-promoting medications. Their US labels cover excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder.[3][2]

Modalert and Waklert: chemical identity and verified product differences

Modalert vs Waklert: Different Active Ingredients

Modalert contains a mixture of R-modafinil and S-modafinil. Waklert contains the R form alone, called armodafinil. This is an ingredient difference, even though both brands are listed by Sun Pharma.[1][3][2]

Our modafinil vs armodafinil guide explains the molecular and pharmacokinetic comparison in detail. The practical brand distinction is that Modalert 200 mg and Waklert 150 mg are different formulations and strengths, not interchangeable pack labels.

Does Waklert Last Longer Than Modalert?

The pharmacokinetic difference is most visible later in the day. An analysis of three randomized single-dose studies found higher late plasma concentrations with armodafinil after adjusting the results to the same dose. Total exposure was also higher, despite similar terminal half-lives of approximately 13 hours.[4]

The authors attributed the difference to the rapid initial elimination of modafinil's S-enantiomer. Armodafinil concentrations declined more evenly after their peak.

The labels give an approximate 15-hour elimination half-life for the usual clinical context. Half-life measures clearance, while a patient's useful period of wakefulness also depends on the diagnosis, sleep schedule and individual response.[3][2]

The existing Modafinil video below introduces the parent compound and its cognitive research.

Modalert vs Waklert: What the Comparative Trial Tested

A 12-week randomized trial compared armodafinil 150 mg with modafinil 200 mg in 211 people with shift work sleep disorder. A response meant improving by at least two grades on the Stanford Sleepiness Scale. Response rates were 72.12% with armodafinil and 74.29% with modafinil, with no statistically significant difference between groups.[5]

Adverse-event rates were also comparable. The study used Emcure armodafinil and commercially sourced modafinil, rather than a direct Waklert-versus-Modalert design.

The relevant result is the similar improvement in diagnosed shift workers at those studied doses. A conversion between individual prescriptions still requires the prescriber to consider the indication and response.

Modalert vs Waklert: Onset and Meals

Modafinil reaches peak concentrations roughly two to four hours after a dose. Food can delay its peak by about one hour. Armodafinil reaches its peak at approximately two hours while fasting, with a delay of around two to four hours after food.[3][2]

Both labels allow administration with or without food. A consistent routine makes it easier to discuss changes in timing or perceived effects with the prescriber.

For excessive sleepiness associated with narcolepsy or sleep apnea, the US labels place dosing in the morning. For shift work disorder, they specify approximately one hour before the work shift. These schedules address diagnosed sleepiness and should follow the individual prescription.

Modalert vs Waklert: Comparing Tolerability

The comparative trial reported similar adverse-event rates for the tested formulations, but it did not test these two Sun Pharma brands. Separate label percentages cannot establish that Modalert or Waklert is safer.[5]

Both ingredients carry serious rash and allergic-reaction warnings. Stop treatment and seek prompt assessment for a new rash; breathing difficulty or facial swelling requires urgent help.[3][2]

See the modafinil safety review and armodafinil safety review for the complete ingredient-specific risks and interactions.

Where to Buy Modalert or Waklert

Product availability follows local medicine approvals and pharmacy rules. Modafinil and armodafinil are Schedule IV prescription medicines in the United States. A licensed pharmacy can identify the approved formulation available for a valid prescription.[3][2]

Compare the active ingredient, prescribed strength, tablet count and total dispensing cost. The price per tablet alone is an incomplete comparison when the tablets contain different medicines or strengths.

For online dispensing, the FDA recommends checking the pharmacy's license, prescription requirement and access to a pharmacist.[6]

References

  1. Sun Pharmaceutical Industries. India products: Modalert and Waklert. Product catalog.
  2. DailyMed. Nuvigil (armodafinil) prescribing information.
  3. DailyMed. Provigil (modafinil) prescribing information.
  4. Darwish M, Kirby M, Hellriegel ET, Robertson P. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies. Clinical drug investigation. 2009;29(9):613-623.
  5. Tembe DV, Dhavale A, Desai H, Mane DN, Raut SK, Dhingra G, Sardesai U, Saoji S, Rohra M, Shinde VG, Padsalge M, Paliwal A, Abbasi K, Devnani P, Papinwar S, Phadke S, Mehta H, Bhailume V. Armodafinil versus Modafinil in Patients of Excessive Sleepiness Associated with Shift Work Sleep Disorder: A Randomized Double Blind Multicentric Clinical Trial. Neurology research international. 2011;2011:514351.
  6. US Food and Drug Administration. BeSafeRx: frequently asked questions.